Spruce Biosciences (SPRB)

• Market cap: $60.4M
• 1 day: -9.11%
• 5 days: -18.15%
• 1 month: 1,098.32%
• 3 months: 994.39%
• 6 months: 994.39%
• Year to date: 240.91%
• 1 year: 153.25%
• 5 years: -93.47%
• 10 years: -91.59%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20